The bottleneck is inside and being paid away

Adaptive Biotechnologies Corporation (ADPT) — this company's answers

The model's full reasoning — Q4 2022 call → NOWe need to answer YES or NO based solely on the transcript. The question asks: does management convey that the main thing standing between the company and meaningfully more business right now is the company's own capability (capacity, people, facilities, throughput, ability to deliver) rather than a shortage of demand, and that the company is already spending real money and effort to remove that internal limit, with the business waiting on the other side already visible today? Need all three: (1) LIVE DEMAND PRESSING IN: real business exceeds or presses against what company can currently produce/deliver etc., grounded in actual current behavior (waiting buyers, stretched lead times, allocated output, work queued). (2) THE LIMIT IS THE COMPANY'S OWN: management identifies own capability as binding constraint. (3) REMOVAL ALREADY UNDERWAY: concrete expansion executing now or committed, not merely planned. Review transcript. Management talks about growth in MRD: clonoSEQ volumes growing, record orders, etc. But do they say they are capacity-constrained? They mention sales force doubled, Epic integration, DLBCL launch. They talk about execution. They mention "we are focused on execution and driving penetration." They talk about having a sales team nearly doubled, now fully trained. They talk about "increased reach and effectiveness of our sales team is coming into play." They talk about community penetration going from 8% to 15% to expected 20%. They talk about ASP growth. Is there any indication that demand exceeds their capability? They say "As we finalize pricing agreements with non-contracted payers and improved collection performance." That is about collection, not capacity. They say "We are off to a great start this year with clinical clonoSEQ orders at a record high for us in the past month." That suggests demand is high, but do they say they can't meet it? No. They talk about "we are focused on execution" - meaning they need to sell more, not that they can't serve. They talk about "Epic integration" which is about ordering, not capacity. They talk about "increased penetration" - they want to grow demand. They are hiring sales force, but that is to drive demand, not to serve excess demand. They don't mention any capacity constraints, backlogs, waiting times, allocation, etc.

← Back to the full ADPT analysis